{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:17:55Z","timestamp":1718486275692},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ejso.2006.02.025","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T13:42:54Z","timestamp":1145454174000},"page":"1114-1118","source":"Crossref","is-referenced-by-count":9,"title":["Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction"],"prefix":"10.1016","volume":"32","author":[{"given":"M.J.","family":"Forshaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gossage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Chrystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Botha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2006.02.025_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000658-200209000-00014","article-title":"Treatment outcomes of resected esophageal cancer","volume":"236","author":"Hofstetter","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2006.02.025_bib2","doi-asserted-by":"crossref","first-page":"463S","DOI":"10.1378\/chest.116.suppl_3.463S","article-title":"Treatment of esophageal carcinoma","volume":"116","author":"Lerut","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ejso.2006.02.025_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0016-5085(99)70175-7","article-title":"Micrometastases in esophagogastric cancer: high detection rate in resected rib segments","volume":"116","author":"O'Sullivan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2006.02.025_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/ASO.2003.03.078","article-title":"Neoadjuvant treatment for respectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomised clinical trials","volume":"10","author":"Kaklamanos","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2006.02.025_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/bjs.4575","article-title":"Neoadjuvant therapy for oesophagogastric cancer","volume":"91","author":"Lordick","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2006.02.025_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without neoadjuvant chemotherapy in oesophageal cancer: a randomised control trial","volume":"359","author":"Medical Research Council Oesophageal Cancer Working Party","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2006.02.025_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/bjs.1800811218","article-title":"Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma","volume":"81","author":"Highley","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2006.02.025_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0959-8049(97)86090-X","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2006.02.025_bib9","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0959-8049(95)00482-3","article-title":"Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)","volume":"31A","author":"Andreyev","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2006.02.025_bib10","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D","article-title":"Epirubicin, Cisplatin and protracted venous infusion of 5-Fluorouracil for esophagogastric adenocarcinoma","volume":"77","author":"Bamias","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2006.02.025_bib11","first-page":"182","article-title":"Preoperative ECF chemotherapy in Gastro-oesophageal adenocarcinoma","volume":"12","author":"Geh","year":"2000","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejso.2006.02.025_bib12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/bjc.1996.604","article-title":"Epirubicin, Cisplatin and continuous infusion 5-Fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer","volume":"74","author":"Melcher","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2006.02.025_bib13","first-page":"4001","article-title":"Perioperative chemotherapy in operable gastric and lower oesophageal cancer. Final results of a randomised controlled trial (the MAGIC trial ISRCTN 93793971)","author":"Cunningham","year":"2005","journal-title":"ASCO abstracts"},{"key":"10.1016\/j.ejso.2006.02.025_bib14","series-title":"TNM classification of malignant tumours","year":"1997"},{"key":"10.1016\/j.ejso.2006.02.025_bib15","series-title":"WHO handbook for reporting results of cancer treatment (publication no. 48)","author":"World Health Organisation","year":"1979"},{"key":"10.1016\/j.ejso.2006.02.025_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","article-title":"Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy","volume":"47","author":"Trotti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2006.02.025_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejso.2006.02.025_bib18","first-page":"164","article-title":"Combined results from three Phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus","volume":"13","author":"Archer","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ejso.2006.02.025_bib19","first-page":"153","article-title":"Neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus","volume":"13","author":"Alderson","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ejso.2006.02.025_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0960-7404(01)00027-5","article-title":"Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies","volume":"10","author":"Lerut","year":"2001","journal-title":"Surg Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2006.02.025_bib21","first-page":"141","article-title":"Surgical outcomes of oesophagogastrectomy: does neo-adjuvant therapy increase the risk? A retrospective audit","volume":"91","author":"Forshaw","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2006.02.025_bib22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/bmj.327.7425.1192","article-title":"Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study","volume":"327","author":"McCulloch","year":"2003","journal-title":"BMJ"},{"issue":"Suppl. 5","key":"10.1016\/j.ejso.2006.02.025_bib23","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/gut.50.suppl_5.v1","article-title":"Guidelines for the management of oesophageal and gastric cancer","volume":"50","author":"Allum","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2006.02.025_bib24","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H","article-title":"Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with respectable esophageal squamous cell carcinoma","volume":"91","author":"Ancona","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2006.02.025_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0748-7983(04)00149-0","article-title":"Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial","volume":"30","author":"Brucher","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2006.02.025_bib26","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1046\/j.1440-1746.17.s1.16.x","article-title":"Predictive factors for success of neoadjuvant therapy in upper gastro-intestinal cancer","volume":"17","author":"Walsh","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2006.02.025_bib27","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2006.02.025_bib28","first-page":"56","article-title":"PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus","volume":"45","author":"Kostakoglu","year":"2004","journal-title":"J Nucl Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:47:19Z","timestamp":1555544839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798306001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0748798306001119"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2006.02.025","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}